Ligand Pharmaceuticals Incorporated Income Statement and Balance Sheet
Income Statement
1998
1999
Revenues
$17.7
$40.9
Net Loss
Before One-time Charges
72.9
67.5
Balance Sheet
1998
1999
Cash & Investments
(1)
Accumulated Deficit
117.9
74.7
$72.5
(395.6)
$49.2
(470.4)
(1) Including restricted cash
2000
2000
$48.1
59.3
72.4
$35.1
(542.7)
After One-time Charges
3Q01 YTD
3Q01
$53.7
29.9
29.9
$41.8
(572.7)
Previous slide
Next slide
Back to first slide
View graphic version